Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/28626
Title: The β+ IVS, I‐NT no. 6 (T→ C) thalassaemia in heterozygotes with an associated Hb Valletta or Hb S heterozygosity in homozygotes from Malta
Authors: Scerri, Christian A.
Abela, W.
Galdies, Ruth
Pizzuto, Monica
Grech, Joseph L.
Felice, Alex
Keywords: beta-Thalassemia
Hemoglobin polymorphisms
Issue Date: 1993
Publisher: Wiley Online Library
Citation: Scerri, C. A., Abela, W., Galdies, R., Pizzuto, M., Grech, J. L., & Felice, A. E. (1993). The β+ IVS, I‐NT no. 6 (T→ C) thalassaemia in heterozygotes with an associated Hb Valletta or Hb S heterozygosity in homozygotes from Malta. British Journal of Haematology, 83(4), 669-671.
Abstract: Summary. In vitro DNA amplification and dot blot analysis with synthetic allele specific oligonucleotides (ASO) identified the β IVS, I‐6 (T→C) thalassaemia in 78% of 32 chromosomes from 16 β‐thalassaemia homozygotes in Malta. The preponderance of a single thalassaemia mutation in one population is unusual. The β+ IVS, I‐6C thalassaemia mutation was also found in three carriers who had an associated β globin heterozygosity, i.e. Hb Valletta (or α2β287PRO) or Hb S (or α2β26VAL). The proportion of Hb A in these cases (av. = 29.7%) provided objective documentation of the relatively mild effect of this mutation on in vivo globin gene expression. However, the expression of homozygous disease was more severe in developing children compared to adults. The β+ IVS, I‐6C mutation complicates population testing because heterozygotes can have Hb A2 levels below those classically associated with β thalassaemia.
URI: https://www.um.edu.mt/library/oar//handle/123456789/28626
Appears in Collections:Scholarly Works - FacM&SPB

Files in This Item:
File Description SizeFormat 
The_β+_IVS_I‐NT_no._6(T→ C)_thalassaemia_in_heterozygotes_with_an associated_Hb-_Valletta_1993.pdf
  Restricted Access
226.55 kBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.